Chromosome 7 harbors many interesting genes, including druggable targets such as the oncogenes EGFR, BRAF and MET, but at present their relation to the retention of chromosome 7 and the development of local recurrent disease in rectal cancer is unclear. This evidence concerns the gene EGFR and rectal cancer.